These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2544533)
1. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection. Halpern NA; Colucci RD; Alicea M; Greenstein R Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):294-7. PubMed ID: 2544533 [TBL] [Abstract][Full Text] [Related]
2. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection. Halpern NA; Colucci RD; Alicea M; Greenstein R Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):250-4. PubMed ID: 2737791 [TBL] [Abstract][Full Text] [Related]
3. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection. Thompson DF; Allen LV; Stiles ML Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585 [No Abstract] [Full Text] [Related]
5. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. Trissel LA; Williams KY; Gilbert DL J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461 [TBL] [Abstract][Full Text] [Related]
6. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Trissel LA; Bready BB Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424 [TBL] [Abstract][Full Text] [Related]
7. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection. Forman JK; Lachs JR; Souney PF Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621 [No Abstract] [Full Text] [Related]
8. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs. Dasta JF; Hale KN; Stauffer GL; Tschampel MM Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093 [TBL] [Abstract][Full Text] [Related]
9. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats. Lin JH; Chen IW; Ulm EH; Duggan DE Drug Metab Dispos; 1988; 16(3):392-6. PubMed ID: 2900730 [TBL] [Abstract][Full Text] [Related]
10. Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed. Lindsey CJ; Bendhack LM; Paiva AC J Pharmacol Exp Ther; 1987 Oct; 243(1):292-6. PubMed ID: 2822902 [TBL] [Abstract][Full Text] [Related]
11. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function. de Zeeuw D; Navis GJ; Donker AJ; de Jong PE J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614 [TBL] [Abstract][Full Text] [Related]
12. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection. Jay GT; Fanikos J; Souney PF Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721 [No Abstract] [Full Text] [Related]